Skip to main content
OpenTrials
Completed

NCT Number: NCT03971279

Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis

VKH disease is a vision threatening condition.The investigators consider that ozurdex intravitreal implant is an effective line of treatment in recurrent VKH posterior uveitis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Posterior Uveitis Eye Diseases Panuveitis Uveal Diseases Uveitis Uveitis, Posterior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

INMC

Abu Dhabi, United Arab Emirates

About this study

Baseline ,and postoperative 1 ,6 ,12 and 24 months full ophthalmic examination was done.

Procedure included intravitreal injection of Dexamethasone implant 0.7 mg (Ozurdex(®); Allergan, Inc, Irvine, CA)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Recurrent VKH posterior uveitis

Exclusion criteria

  • retinal pathology, other causes of posterior uveitis

Treatment and study plan

Dexamethasone Ophthalmic implant

Drug

intravitreal injection of ozurdex implant

Other names: ozurdex implant

Primary outcomes

  1. Best corrected visual acuity (BCVA)

    Time frame: 2 years

    Change in BCVA

Secondary outcomes

  1. optical coherence tomography (OCT) foveal thickness

    Time frame: 2 years

    changes in central foveal thickness

Sponsors and collaborators

Lead sponsor

Benha University

Other

Registry information

Official study title

Long Term Efficacy of Dexamethasone Intravitreal Implant (Ozurdex®) in Treatment of Recurrent VKH Uveitis

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jun 3, 2019
Registry last updated
Nov 26, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.